Microglial TonEBP mediates LPS-induced inflammation and memory loss as transcriptional cofactor for NF-κB and AP-1

Gyu Won Jeong1, Hwan Hee Lee1, Whaseon Lee-Kwon1

  • 1School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea.

Abstract

Insights

Transcription factor TonEBP mediates microglial activation and neuroinflammation. Blocking TonEBP with cerulenin reduces LPS-induced microglial activation and neuronal damage, offering therapeutic potential for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia, the brain's immune cells, are implicated in neurodegenerative diseases.
  • TonEBP acts as a transcriptional cofactor for NF-κB in macrophages, promoting pro-inflammatory gene expression.
  • The specific role of microglial TonEBP in neuroinflammation was investigated.

Purpose of the Study:

  • To elucidate the function of TonEBP in microglia.
  • To determine TonEBP's role in lipopolysaccharide (LPS)-induced neuroinflammation.
  • To evaluate cerulenin as a potential therapeutic agent targeting TonEBP.

Main Methods:

  • Utilized BV2 microglial cell line and lentiviral shRNA for TonEBP knockdown.
  • Generated myeloid-specific TonEBP knockout mice.
  • Employed cerulenin to inhibit TonEBP's cofactor activity.

Main Results:

  • TonEBP deficiency suppressed LPS-induced pro-inflammatory cytokine and enzyme expression in BV2 cells.
  • TonEBP was identified as a cofactor for both NF-κB and AP-1 transcription factors.
  • Myeloid-specific TonEBP deletion prevented LPS-induced microglia activation, neuronal death, and memory deficits.
  • Cerulenin disrupted the TonEBP/NF-κB/AP-1/p300 complex, mitigating microglial activation and neuronal damage in vivo.

Conclusions:

  • TonEBP is a critical mediator of microglial activation and neuroinflammation.
  • Targeting TonEBP with cerulenin effectively inhibits neuroinflammatory processes and associated neuronal damage.